UWSpace is currently experiencing technical difficulties resulting from its recent migration to a new version of its software. These technical issues are not affecting the submission and browse features of the site. UWaterloo community members may continue submitting items to UWSpace. We apologize for the inconvenience, and are actively working to resolve these technical issues.
 

Membrane binding and oligomer formation by the calcium-dependent lipopeptide antibiotic A54145: a quantitative study with pyrene excimer fluorescence

dc.contributor.authorZhang, TianHua
dc.contributor.authorTaylor, Scott D.
dc.contributor.authorPalmer, Michael
dc.contributor.authorDuhamel, Jean
dc.date.accessioned2017-04-21T19:21:48Z
dc.date.available2017-04-21T19:21:48Z
dc.date.issued2016-09-20
dc.descriptionThe final publication is available at Elsevier via http://doi.org/10.1016/j.bpj.2016.07.018 © 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/en
dc.description.abstractA54145 is a lipopeptide antibiotic related to daptomycin that permeabilizes bacterial cell membranes. Its action requires both calcium and phosphatidylglycerol in the target membrane, and it is accompanied by the formation of membrane-associated oligomers. We here probed the interaction of A54145 with model membranes composed of dimyristoylphosphatidylcholine and dimyristoylphosphatidylglycerol, using the steady-state and time-resolved fluorescence of a pyrene-labeled derivative (Py-A54145). In solution, the labeled peptide was found to exist as a monomer. Its membrane interaction occurred in two stages that could be clearly distinguished by varying the calcium concentration. In the first stage, which was observed between 0.15 and 1 mM calcium, Py-A54145 bound to the membrane, as indicated by a strong increase in pyrene monomer emission. At the same calcium concentration, excimer emission increased also, suggesting that Py-A54145 had oligomerized. A global analysis of the time-resolved pyrene monomer and excimer fluorescence confirmed that Py-A54145 forms oligomers quantitatively and concomitantly with membrane binding. When calcium was raised beyond 1 mM, a distinct second transition was observed that may correspond to a doubling of the number of oligomer subunits. The collective findings confirm and extend our understanding of the action mode of A54145 and daptomycin.en
dc.description.sponsorshipThis work was supported by the Natural Sciences and Engineering Research Council of Canada operating grants to J.D. (201603-2013), M.P. (250265-2013), and S.T. (155283-2012).en
dc.identifier.urihttps://doi.org/10.1016/j.bpj.2016.07.018
dc.identifier.urihttp://hdl.handle.net/10012/11715
dc.language.isoenen
dc.publisherElsevieren
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectExcimer fluorescenceen
dc.subjectSolvent polaritiesen
dc.subjectPy Scaleen
dc.subjectDaptomycinen
dc.subjectPolymeren
dc.subjectModelen
dc.subjectMacromoleculesen
dc.subjectAssociationen
dc.subjectTransitionsen
dc.subjectInhibitionen
dc.titleMembrane binding and oligomer formation by the calcium-dependent lipopeptide antibiotic A54145: a quantitative study with pyrene excimer fluorescenceen
dc.typeArticleen
dcterms.bibliographicCitationZhang, T., Taylor, S. D., Palmer, M., & Duhamel, J. (2016). Membrane Binding and Oligomerization of the Lipopeptide A54145 Studied by Pyrene Fluorescence. Biophysical Journal, 111(6), 1267–1277. https://doi.org/10.1016/j.bpj.2016.07.018en
uws.contributor.affiliation1Faculty of Scienceen
uws.contributor.affiliation2Chemistryen
uws.peerReviewStatusRevieweden
uws.scholarLevelFacultyen
uws.typeOfResourceTexten

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
revision2s.pdf
Size:
491.16 KB
Format:
Adobe Portable Document Format
Description:
Post-print
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
4.46 KB
Format:
Item-specific license agreed upon to submission
Description: